StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.79−0.00 (-0.24%)

Close on Nov 17, 2026Market cap $11.93MP/E –Yield –

BioCardia revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioCardia's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $1.35M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$58.00K-87.8%
FY2023Dec 31, 2023$477.00K-64.7%
FY2022Dec 31, 2022$1.35M+33.2%
FY2021Dec 31, 2021$1.02M+600.0%
FY2020Dec 31, 2020$145.00K-79.6%
FY2019Dec 31, 2019$710.00K+13.6%
FY2018Dec 31, 2018$625.00K+30.5%
FY2017Dec 31, 2017$479.00K-16.8%
FY2016Dec 31, 2016$576.00K-36.3%
FY2015Dec 31, 2015$904.00K+7433.3%
FY2011Dec 31, 2011$12.00K–
FY2010Dec 31, 2010$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$3.00K-93.0%
Q1 FY2024Mar 31, 2024$55.00K-14.1%
Q4 FY2023Dec 31, 2023$13.00K-87.7%
Q3 FY2023Sep 30, 2023$357.00K+68.4%
Q2 FY2023Jun 30, 2023$43.00K-95.6%
Q1 FY2023Mar 31, 2023$64.00K+6.7%
Q4 FY2022Dec 31, 2022$106.00K+34.2%
Q3 FY2022Sep 30, 2022$212.00K-74.2%
Q2 FY2022Jun 30, 2022$974.00K+1311.6%
Q1 FY2022Mar 31, 2022$60.00K+30.4%
Q4 FY2021Dec 31, 2021$79.00K+71.7%
Q3 FY2021Sep 30, 2021$821.00K+2314.7%
Q2 FY2021Jun 30, 2021$69.00K+155.6%
Q1 FY2021Mar 31, 2021$46.00K+21.1%
Q4 FY2020Dec 31, 2020$46.00K-78.6%
Q3 FY2020Sep 30, 2020$34.00K-82.5%
Q2 FY2020Jun 30, 2020$27.00K-68.6%
Q1 FY2020Mar 31, 2020$38.00K-82.4%
Q4 FY2019Dec 31, 2019$215.00K+108.7%
Q3 FY2019Sep 30, 2019$194.00K+131.0%
Q2 FY2019Jun 30, 2019$86.00K-64.0%
Q1 FY2019Mar 31, 2019$216.00K+8.5%
Q4 FY2018Dec 31, 2018$103.00K+3.0%
Q3 FY2018Sep 30, 2018$84.00K-35.4%
Q2 FY2018Jun 30, 2018$239.00K+113.4%
Q1 FY2018Mar 31, 2018$199.00K+45.3%
Q4 FY2017Dec 31, 2017$100.00K-27.0%
Q3 FY2017Sep 30, 2017$130.00K+11.1%
Q2 FY2017Jun 30, 2017$112.00K–
Q1 FY2017Mar 31, 2017$137.00K–
Q4 FY2016Dec 31, 2016$137.00K–
Q3 FY2016Sep 30, 2016$117.00K–

More BioCardia figures

See a number that looks wrong?